Butterfly Network (BFLY) UBS Global Healthcare Conference summary
Event summary combining transcript, slides, and related documents.
UBS Global Healthcare Conference summary
10 Nov, 2026Strategy and POCUS adoption
Vision centers on making imaging accessible wherever patients receive care, with ultrasound becoming as routine as a stethoscope; POCUS is increasingly standard in emergency medicine and ICUs.
Ultrasound’s operator learning curve and a US base of 82,000 ultrasonographers constrain access; training clinicians on focused use cases and AI image-acquisition tools aim to speed adoption.
About 80% of medical schools teach with Butterfly devices, while AI guidance can help novices acquire scans in ambulances and other care settings.
Home and community care
Community-care model trains nurses, deploys devices and software at no cost, integrates workflows, and charges per patient and per scan.
A nationwide at-risk provider partnership targets skilled nursing facilities; each avoided admission or readmission was valued at $10,000 or more by management.
Nurses scan for pulmonary congestion and send images to remote cardiologists for review and medication guidance; an early nursing-home scan also detected a misplaced Foley catheter.
Revenue from the program is starting, and discussions with other large payer-providers support management’s expectation of a sizable business.
Enterprise software and deals
Compass middleware routes POCUS data into EMRs, DICOM records and revenue-cycle systems, and works with competing devices; historically, only 30% of POCUS images entered hospital systems and 70% were undocumented and unpaid.
Enterprise contracts are typically three or five years, with six- or seven-figure TCV; revenue begins after implementation and is recognized in monthly installments.
Deals are expanding from single departments to multi-department deployments; one health system grew to more than 800 devices, with purchases accumulating over time.
Latest events from Butterfly Network
- Revenue rose 51.7%, gross margin reached 73%, and FY26 guidance increased.BFLY
Q3 2026 - Platform strategy and key partnerships drive expansion into new markets and recurring revenue growth.BFLY
Morgan Stanley 24th Annual Global Healthcare Conference - Q2 2026 revenue up 39.5% to $32.6M, gross margin 71.4%, and Embedded partnerships drove growth.BFLY
Q2 2026 - Directors elected, auditor ratified, and executive compensation approved with no stockholder questions.BFLY
AGM 2026 - Semiconductor ultrasound tech, AI ecosystem, and licensing drive growth and industry expansion.BFLY
46th Annual William Blair Growth Stock Conference - AI-powered ultrasound and embedded tech drive global growth and financial improvement.BFLY
Bank of America Global Healthcare Conference 2026 - Q1 2026 revenue up 25%, gross margin at 68.9%, and adjusted EBITDA loss narrowed to $6.1M.BFLY
Q1 2026 - Proxy covers director elections, auditor ratification, and executive pay, with founder holding voting control.BFLY
Proxy filing - Votes include director elections, auditor ratification, and executive pay approval.BFLY
Proxy filing